Literature DB >> 1048860

Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital.

J J Klimek, F J Marsik, R C Bartlett, B Weir, P Shea, R Quintiliani.   

Abstract

Over a 12 month period, 61 isolates of methicillin-resistant Staphylococcus aureus (MR-SA) were obtained in 23 hospitalized patients. Eight-six per cent of the patients were over 50 years of age, and 91 per cent were in the postoperative period. In 10 patients (42 per cent), MR-SA was the major pathogen, producing either pneumonia, empyema, osteomyelitis, lung abscess, enterocolitis, wound infection or bacteremia with sepsis. Three patients in this group died despite therapy with antibiotics with in vitro activity against these organisms. All the patients probably acquired their MR-SA in the hospital, and five carriers of the organism were identified among hospital personnel. This outbreak demonstrates the ability of MR-SA not only to colonize many patients in a relatively brief period of time, but also to produce serious disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1048860     DOI: 10.1016/0002-9343(76)90370-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  52 in total

1.  Methicillin-resistant strains of Staphylococcus aureus phage type 92.

Authors:  S Schaefler; W Perry; D Jones
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

Review 2.  MRSA and the environment: implications for comprehensive control measures.

Authors:  N Cimolai
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-14       Impact factor: 3.267

3.  Efficacy of short courses of oral novobiocin-rifampin in eradicating carrier state of methicillin-resistant Staphylococcus aureus and in vitro killing studies of clinical isolates.

Authors:  E G Arathoon; J R Hamilton; C E Hench; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

4.  Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline.

Authors:  Jennifer Dien Bard; Janet A Hindler; Howard S Gold; Brandi Limbago
Journal:  Clin Infect Dis       Date:  2014-01-22       Impact factor: 9.079

5.  Role of beta-lactamase and different testing conditions in oxacillin-borderline-susceptible staphylococci.

Authors:  J G Sierra-Madero; C Knapp; C Karaffa; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

6.  Bactericidal activity of oxacillin against beta-lactamase-hyperproducing Staphylococcus aureus.

Authors:  G L Woods; P Yam
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

7.  Rapid recognition of methicillin-resistant Staphylococcus aureus by use of automated test systems.

Authors:  J H Jorgensen; J Redding; J E Johnson; V Holloway; R J Almeida
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

8.  Activity of ten cephalosporins on biomass of methicillin-susceptible and -resistant Staphylococcus aureus.

Authors:  E Yourassowsky; M P Van der Linden; M J Lismont; F Crokaert
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

9.  Use of a heavy inoculum in the in vitro evaluation of the anti-staphylococcal activity of 19 cephalosporins.

Authors:  M Laverdiere; D Welter; L D Sabath
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

10.  Impact of methicillin-resistant Staphylococcus aureus on treatment of hand infections.

Authors:  Scott D Lifchez; David A Harriman
Journal:  Eplasty       Date:  2009-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.